help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Labrie, F.
Right arrow Articles by Pelletier, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labrie, F.
Right arrow Articles by Pelletier, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Breast Cancer
*Menopause
Endocrine Reviews 24 (2): 152-182
Copyright © 2003 by The Endocrine Society

Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone

Fernand Labrie, Van Luu-The, Claude Labrie, Alain Bélanger, Jacques Simard, Sheng-Xiang Lin and Georges Pelletier

Molecular Endocrinology and Oncology Research Center, Laval University Medical Center (Centre Hospitalier de l’Université Laval) and Laval University, Québec City, Québec G1V 4G2, Canada

Correspondence: Address all correspondence and requests for reprints to: Prof. Fernand Labrie, Molecular Endocrinology and Oncology Research Center, Laval University Medical Center (Centre Hospitalier de l’Université Laval), 2705 Laurier Boulevard, Québec City, Québec G1V 4G2, Canada. E-mail: fernand.labrie{at}crchul.ulaval.ca

Serum androgens as well as their precursors and metabolites decrease from the age of 30–40 yr in women, thus suggesting that a more physiological hormone replacement therapy at menopause should contain an androgenic compound. It is important to consider, however, that most of the androgens in women, especially after menopause, are synthesized in peripheral intracrine tissues from the inactive precursors dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEA-S) of adrenal origin. Much progress in this new area of endocrine physiology called intracrinology has followed the cloning and characterization of most of the enzymes responsible for the transformation of DHEA and DHEA-S into androgens and estrogens in peripheral target tissues, where the locally produced sex steroids are exerting their action in the same cells in which their synthesis takes place without significant diffusion into the circulation, thus seriously limiting the interpretation of serum levels of active sex steroids. The sex steroids made in peripheral tissues are then inactivated locally into more water-soluble compounds that diffuse into the general circulation where they can be measured. In a series of animal models, androgens and DHEA have been found to inhibit breast cancer development and growth and to stimulate bone formation. In clinical studies, DHEA has been found to increase bone mineral density and to stimulate vaginal maturation without affecting the endometrium, while improving well-being and libido with no significant side effects. The advantage of DHEA over other androgenic compounds is that DHEA, at physiological doses, is converted into androgens and/or estrogens only in the specific intracrine target tissues that possess the appropriate physiological enzymatic machinery, thus limiting the action of the sex steroids to those tissues possessing the tissue-specific profile of expression of the genes responsible for their formation, while leaving the other tissues unaffected and thus minimizing the potential side effects observed with androgens or estrogens administered systemically.




This article has been cited by other articles:


Home page
 Menopause IntHome page
C. L Shufelt and G. D Braunstein
Testosterone and the breast
Menopause Int, September 1, 2008; 14(3): 117 - 122.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
N. E Allen, T. J Key, L. Dossus, S. Rinaldi, A. Cust, A. Lukanova, P. H Peeters, N C. Onland-Moret, P. H Lahmann, F. Berrino, et al.
Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Endocr. Relat. Cancer, June 1, 2008; 15(2): 485 - 497.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
M. Plourde, C. Manhes, G. Leblanc, F. Durocher, M. Dumont, O. Sinilnikova, I. BRCAs, and J. Simard
Mutation analysis and characterization of HSD17B2 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer
J. Mol. Endocrinol., April 1, 2008; 40(4): 161 - 172.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Swanson, D. Mellstrom, M. Lorentzon, L. Vandenput, J. Jakobsson, A. Rane, M. Karlsson, O. Ljunggren, U. Smith, A.-L. Eriksson, et al.
The Uridine Diphosphate Glucuronosyltransferase 2B15 D85Y and 2B17 Deletion Polymorphisms Predict the Glucuronidation Pattern of Androgens and Fat Mass in Men
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4878 - 4882.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Chouinard, O. Barbier, and A. Belanger
UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 Enzymes Are Major Determinants of the Androgen Response in Prostate Cancer LNCaP Cells
J. Biol. Chem., November 16, 2007; 282(46): 33466 - 33474.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
M. S. Cooper and P. M. Stewart
Adrenal Insufficiency in Critical Illness
J Intensive Care Med, November 1, 2007; 22(6): 348 - 362.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Vandenput, D. Mellstrom, M. Lorentzon, C. Swanson, M. K. Karlsson, J. Brandberg, L. Lonn, E. Orwoll, U. Smith, F. Labrie, et al.
Androgens and Glucuronidated Androgen Metabolites Are Associated with Metabolic Risk Factors in Men
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4130 - 4137.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
G. D. Braunstein
Gynecomastia
N. Engl. J. Med., September 20, 2007; 357(12): 1229 - 1237.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Zhongyi, P. Rantakari, T. Lamminen, J. Toppari, and M. Poutanen
Transgenic Male Mice Expressing Human Hydroxysteroid Dehydrogenase 2 Indicate a Role for the Enzyme Independent of Its Action on Sex Steroids
Endocrinology, August 1, 2007; 148(8): 3827 - 3836.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S. N. Birrell, L. M. Butler, J. M. Harris, G. Buchanan, and W. D. Tilley
Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer
FASEB J, August 1, 2007; 21(10): 2285 - 2293.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev., June 1, 2007; 28(4): 387 - 439.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
M. Panjari and S. R. Davis
DHEA therapy for women: effect on sexual function and wellbeing
Hum. Reprod. Update, May 1, 2007; 13(3): 239 - 248.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. Rinaldi, L. Dossus, A. Lukanova, P. H.M. Peeters, N. E. Allen, T. Key, S. Bingham, K.-T. Khaw, D. Trichopoulos, A. Trichopoulou, et al.
Endogenous Androgens and Risk of Epithelial Ovarian Cancer: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 23 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Tworoger, A. H. Eliassen, S. A. Missmer, H. Baer, J. Rich-Edwards, K. B. Michels, R. L. Barbieri, M. Dowsett, and S. E. Hankinson
Birthweight and Body Size throughout Life in Relation to Sex Hormones and Prolactin Concentrations in Premenopausal Women
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2494 - 2501.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. L. Eriksson, M. Lorentzon, D. Mellstrom, L. Vandenput, C. Swanson, N. Andersson, G. L. Hammond, J. Jakobsson, A. Rane, E. S. Orwoll, et al.
SHBG Gene Promoter Polymorphisms in Men Are Associated with Serum Sex Hormone-Binding Globulin, Androgen and Androgen Metabolite Levels, and Hip Bone Mineral Density
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5029 - 5037.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Grube, K. Kock, S. Karner, S. Reuther, C. A. Ritter, G. Jedlitschky, and H. K. Kroemer
Modification of OATP2B1-Mediated Transport by Steroid Hormones
Mol. Pharmacol., November 1, 2006; 70(5): 1735 - 1741.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
G. Perez-Palacios, R. Santillan, R. Garcia-Becerra, E. Borja-Cacho, F. Larrea, P. Damian-Matsumura, L. Gonzalez, and A. E Lemus
Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
J. Endocrinol., September 1, 2006; 190(3): 805 - 818.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. E. Sherman, J. V. Lacey, S. S. Buys, D. J. Reding, C. D. Berg, C. Williams, and P. Hartge
Ovarian Volume: Determinants and Associations with Cancer among Postmenopausal Women.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1550 - 1554.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
M. H. Slagter, L. J.G. Gooren, A. Scorilas, C. D. Petraki, and E. P. Diamandis
Effects of Long-term Androgen Administration on Breast Tissue of Female-to-Male Transsexuals
J. Histochem. Cytochem., August 1, 2006; 54(8): 905 - 910.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. F. Macedo, Z. Guo, S. L. Tilghman, G. J. Sabnis, Y. Qiu, and A. Brodie
Role of androgens on mcf-7 breast cancer cell growth and on the inhibitory effect of letrozole.
Cancer Res., August 1, 2006; 66(15): 7775 - 7782.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. Arlt, F. Hammer, P. Sanning, S. K. Butcher, J. M. Lord, B. Allolio, D. Annane, and P. M. Stewart
Dissociation of Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate in Septic Shock
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2548 - 2554.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
F Labrie
Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 335 - 355.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Tworoger, S. A. Missmer, A. H. Eliassen, D. Spiegelman, E. Folkerd, M. Dowsett, R. L. Barbieri, and S. E. Hankinson
The Association of Plasma DHEA and DHEA Sulfate with Breast Cancer Risk in Predominantly Premenopausal Women.
Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 967 - 971.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Juhasz-Vedres, E. Rozsa, G. Rakos, M. B. Dobszay, Z. Kis, J. Wolfling, J. Toldi, A. Parducz, and T. Farkas
Dehydroepiandrosterone Sulfate Is Neuroprotective when Administered Either before or after Injury in a Focal Cortical Cold Lesion Model
Endocrinology, February 1, 2006; 147(2): 683 - 686.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. C. Havelock, W. E. Rainey, K. D. Bradshaw, and B. R. Carr
The post-menopausal ovary displays a unique pattern of steroidogenic enzyme expression
Hum. Reprod., January 1, 2006; 21(1): 309 - 317.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
T. Suzuki, Y. Miki, Y. Nakamura, T. Moriya, K. Ito, N. Ohuchi, and H. Sasano
Sex steroid-producing enzymes in human breast cancer
Endocr. Relat. Cancer, December 1, 2005; 12(4): 701 - 720.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
R Kaaks, S Rinaldi, T J Key, F Berrino, P H M Peeters, C Biessy, L Dossus, A Lukanova, S Bingham, K-T Khaw, et al.
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition
Endocr. Relat. Cancer, December 1, 2005; 12(4): 1071 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. J. Bettoun, A. Scafonas, S. J. Rutledge, P. Hodor, O. Chen, C. Gambone, R. Vogel, S. McElwee-Witmer, C. Bai, L. Freedman, et al.
Interaction between the Androgen Receptor and RNase L Mediates a Cross-talk between the Interferon and Androgen Signaling Pathways
J. Biol. Chem., November 25, 2005; 280(47): 38898 - 38901.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie
Is dehydroepiandrosterone a hormone?
J. Endocrinol., November 1, 2005; 187(2): 169 - 196.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. G. Schwartz, G. M. Prysak, V. Murphy, F. Lonardo, H. Pass, J. Schwartz, and S. Brooks
Nuclear Estrogen Receptor {beta} in Lung Cancer: Expression and Survival Differences by Sex
Clin. Cancer Res., October 15, 2005; 11(20): 7280 - 7287.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Buchanan, S. N. Birrell, A. A. Peters, T. Bianco-Miotto, K. Ramsay, E. J. Cops, M. Yang, J. M. Harris, H. A. Simila, N. L. Moore, et al.
Decreased Androgen Receptor Levels and Receptor Function in Breast Cancer Contribute to the Failure of Response to Medroxyprogesterone Acetate
Cancer Res., September 15, 2005; 65(18): 8487 - 8496.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Bhasin
Female Androgen Deficiency Syndrome--An Unproven Hypothesis
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4970 - 4972.
[Full Text] [PDF]

Home page
 JAMAHome page
S. R. Davis, S. L. Davison, S. Donath, and R. J. Bell
Circulating Androgen Levels and Self-reported Sexual Function in Women
JAMA, July 6, 2005; 294(1): 91 - 96.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner
Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family
Endocr. Rev., June 1, 2005; 26(4): 525 - 582.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Hammer, S. Subtil, P. Lux, C. Maser-Gluth, P. M. Stewart, B. Allolio, and W. Arlt
No Evidence for Hepatic Conversion of Dehydroepiandrosterone (DHEA) Sulfate to DHEA: In Vivo and in Vitro Studies
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3600 - 3605.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
R. Kaaks, F. Berrino, T. Key, S. Rinaldi, L. Dossus, C. Biessy, G. Secreto, P. Amiano, S. Bingham, H. Boeing, et al.
Serum Sex Steroids in Premenopausal Women and Breast Cancer Risk Within the European Prospective Investigation into Cancer and Nutrition (EPIC)
J Natl Cancer Inst, May 18, 2005; 97(10): 755 - 765.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
E. R. Simpson, M. Misso, K. N. Hewitt, R. A. Hill, W. C. Boon, M. E. Jones, A. Kovacic, J. Zhou, and C. D. Clyne
Estrogen--the Good, the Bad, and the Unexpected
Endocr. Rev., May 1, 2005; 26(3): 322 - 330.
[Full Text] [PDF]

Home page
 Endocr. Rev.Home page
F. Labrie, A. Belanger, V. Luu-The, C. Labrie, J. Simard, L. Cusan, J. Gomez, and B. Candas
Gonadotropin-Releasing Hormone Agonists in the Treatment of Prostate Cancer
Endocr. Rev., May 1, 2005; 26(3): 361 - 379.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Townsend, C. M. Banwell, M. Guy, K. W. Colston, J. L. Mansi, P. M. Stewart, M. J. Campbell, and M. Hewison
Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue
Clin. Cancer Res., May 1, 2005; 11(9): 3579 - 3586.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
F. Labrie, V. Luu-The, E. Calvo, C. Martel, J. Cloutier, S. Gauthier, P. Belleau, J. Morissette, M.-H. Levesque, and C. Labrie
Tetrahydrogestrinone induces a genomic signature typical of a potent anabolic steroid
J. Endocrinol., February 1, 2005; 184(2): 427 - 433.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Lukanova and R. Kaaks
Endogenous Hormones and Ovarian Cancer: Epidemiology and Current Hypotheses
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 98 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
J. J. Christiansen, C. H. Gravholt, S. Fisker, N. Moller, M. Andersen, B. Svenstrup, P. Bennett, P. Ivarsen, J. S. Christiansen, and J. O. L. Jorgensen
Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism
Eur. J. Endocrinol., January 1, 2005; 152(1): 77 - 85.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. H. Payne and D. B. Hales
Overview of Steroidogenic Enzymes in the Pathway from Cholesterol to Active Steroid Hormones
Endocr. Rev., December 1, 2004; 25(6): 947 - 970.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
G. Pelletier, V. Luu-The, S. Li, J. Ouellet, and F. Labrie
Cellular Localization of mRNA Expression of Enzymes Involved in the Formation and Inactivation of Hormonal Steroids in the Mouse Prostate
J. Histochem. Cytochem., October 1, 2004; 52(10): 1351 - 1356.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Nakamura, M. Yoshimura, M. Nakayama, T. Ito, Y. Mizuno, E. Harada, T. Sakamoto, Y. Saito, K. Nakao, H. Yasue, et al.
Possible Association of Heart Failure Status With Synthetic Balance Between Aldosterone and Dehydroepiandrosterone in Human Heart
Circulation, September 28, 2004; 110(13): 1787 - 1793.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. J. MacLusky, T. Hajszan, and C. Leranth
Effects of Dehydroepiandrosterone and Flutamide on Hippocampal CA1 Spine Synapse Density in Male and Female Rats: Implications for the Role of Androgens in Maintenance of Hippocampal Structure
Endocrinology, September 1, 2004; 145(9): 4154 - 4161.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
L.M. Rivera-Woll, M. Papalia, S.R. Davis, and H.G. Burger
Androgen insufficiency in women: diagnostic and therapeutic implications
Hum. Reprod. Update, September 1, 2004; 10(5): 421 - 432.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. T. Chatterton Jr., A. S. Geiger, S. A. Khan, I. B. Helenowski, B. D. Jovanovic, and P. H. Gann
Variation in Estradiol, Estradiol Precursors, and Estrogen-related Products in Nipple Aspirate Fluid from Normal Premenopausal Women
Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 928 - 935.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
W. Somboonporn and S. R. Davis
Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women
Endocr. Rev., June 1, 2004; 25(3): 374 - 388.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. E. Wood, J. M. Cline, M. S. Anthony, T. C. Register, and J. R. Kaplan
Adrenocortical Effects of Oral Estrogens and Soy Isoflavones in Female Monkeys
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2319 - 2325.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Leblanc, M.-C. Belanger, P. Julien, A. Tchernof, C. Labrie, A. Belanger, and F. Labrie
Plasma Lipoprotein Profile in the Male Cynomolgus Monkey under Normal, Hypogonadal, and Combined Androgen Blockade Conditions
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1849 - 1857.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Hajszan, N. J. MacLusky, and C. Leranth
Dehydroepiandrosterone Increases Hippocampal Spine Synapse Density in Ovariectomized Female Rats
Endocrinology, March 1, 2004; 145(3): 1042 - 1045.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Neves-e-Castro
Menopause in crisis post-Women's Health Initiative? A view based on personal clinical experience
Hum. Reprod., December 1, 2003; 18(12): 2512 - 2518.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Leblanc, C. Labrie, A. Belanger, B. Candas, and F. Labrie
Bioavailability and Pharmacokinetics of Dehydroepiandrosterone in the Cynomolgus Monkey
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4293 - 4302.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society